How Pharma and Its Consultants Abuse the Patent System
Investigating the pharmaceutical industry’s drug patenting practices
Dec 2023: Patent Abuse is Front-Page News
Blueprint to Address Patent Thickets, Improve Competition, and Lower Prescription Drug Prices
Oct. 2023: How Egregious Orange Book Manipulation Extended an Insulin Monopoly
The COVID-19 Vaccine Patent Waiver Fight Is Far From Over
Patently unfair: Can waivers help solve COVID vaccine inequality?
The Path to Racial Justice Runs Through This Agency
The EU Wants to Maintain a System That Harms its Citizens
We Need to Take On Drug Companies’ Abuse of the Patent System